Jenny van Asbeck

Company: Mercurna

Job title: Chief Executive Officer

Seminars:

Targeted mRNA Therapeutics for Treatment of Kidney Diseases 4:30 pm

Mercurna’s technology platform combines unique cell-targeting moieties, with a lipid-based delivery vehicle to deliver engineered mRNA with high specificity Active targeting strategies through optimised technology on targeted LNPs Showcasing examples on how Mercurna leverages its platform for development of targeted mRNA therapeutics to treat kidney diseasesRead more

day: Day One PM

CEOs’ Fireside Chat 11:00 am

With the next wave of mRNA medicines approaching, and companies who were involved pre- pandemic now utilising validated platforms to develop new therapeutics and vaccines, this leads to the inevitable question: What comes next? We now need to realise the opportunities of such mRNA- based therapeutic applications, as we hear from the leaders of the…Read more

day: Pre-Conference Day AM